| [1] |
Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence[J]. Ann N Y Acad Sci, 2000, 908:244-254.
|
| [2] |
Sayed N, Huang Y, Nguyen K, et al. An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging[J]. Nat Aging, 2021, 1:598-615.
|
| [3] |
Gómez-Rubio P, Trapero I, Cauli O, et al. Salivary IL-6 concentration is associated with frailty syndrome in older individuals[J]. Diagnostics (Basel), 2022, 12(1):117.
|
| [4] |
Tembo MC, Holloway-Kew KL, Bortolasci CC, et al. Association between serum interleukin-6 and frailty in older men: cross-sectional data[J]. Eur Geriatr Med, 2021, 12(4):887-892.
|
| [5] |
Samson LD, Buisman AM, Ferreira JA, et al. Inflammatory marker trajectories associated with frailty and ageing in a 20-year longitudinal study[J/OL]. Clin Transl Immunology, 2022, 11(2):e1374.
|
| [6] |
Jergović M, Thompson HL, Bradshaw CM, et al. IL-6 can singlehandedly drive many features of frailty in mice[J]. Geroscience, 2021, 43(2):539-549.
|
| [7] |
Mourtzi N, Georgakis M, Ntanasi E, et al. Genetically downregulated Interleukin-6 signalling is associated with a lower risk of frailty[J]. Age Ageing, 2023, 52(1):afac318[pii].
|
| [8] |
Xu T, Xia R, He F, et al. 5-Hydroxymethylfurfural induces mice frailty through cell senescence-associated sarcopenia caused by chronic inflammation[J/OL]. Heliyon, 2023, 9(2):e13217.
|
| [9] |
Kochar BD, Cai W, Ananthakrishnan AN. Inflammatory bowel disease patients who respond to treatment with anti-tumor necrosis factor agents demonstrate improvement in pre-treatment frailty[J]. Dig Dis Sci, 2022, 67(2):622-628.
|
| [10] |
Cho HC, Huang Y, Hung JT, et al. Puf-A promotes cancer progression by interacting with nucleophosmin in nucleolus[J]. Oncogene, 2022, 41(8):1155-1165.
|
| [11] |
Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes[J]. Cell, 2021, 184(1):149-168.e17.
|
| [12] |
Kane AE, Keller KM, Heinze-milne S, et al. A murine frailty index based on clinical and laboratory measurements:cLinks between frailty and pro-inflammatory cytokines differ in a sex-specific manner[J]. J Gerontol A Biol Sci Med Sci, 2019, 74(3):275-282.
|
| [13] |
Edvardsson M, Sund-Levander M, Milberg A, et al. Elevated levels of CRP and IL-8 are related to reduce survival time: 1-year follow-up measurements of different analytes in frail elderly nursing home residents[J]. Scand J Clin Lab Invest, 2019, 79(5):288-292.
|
| [14] |
Hammami S, Ghzaiel I, Hammouda S, et al. Evaluation of pro-inflammatory cytokines in frail Tunisian older adults[J/OL]. PLoS One, 2020, 15(11):e0242152.
|
| [15] |
Goldberg EL, Dixit VD. Drivers of age-related inflammation and strategies for healthspan extension[J]. Immunol Rev, 2015, 265(1):63-74.
|
| [16] |
Palmer J, Pandit V, Zeeshan M, et al. The acute inflammatory response after trauma is heightened by frailty: A prospective evaluation of inflammatory and endocrine system alterations in frailty[J]. J Trauma Acute Care Surg, 2019, 87(1):54-60.
|
| [17] |
Juárez-Cedillo T, Vargas-Alarcón G, Martínez-Rodríguez N, et al. Interleukin 10 gene polymorphisms and frailty syndrome in elderly Mexican people: (Sadem study)[J/OL]. Mol Genet Genomic Med, 2019, 7(9):e918.
|
| [18] |
Asadi Shahmirzadi A, Edgar D, Liao CY, et al. Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice[J]. Cell Metab, 2020, 32(3):447-456.e6.
|
| [19] |
Li CW, Yu K, Shyh-Chang N, et al. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention[J]. J Cachexia Sarcopenia Muscle, 2019, 10(3):586-600.
|
| [20] |
Samson LD, Engelfriet P, Verschuren W, et al. Impaired JAK-STAT pathway signaling in leukocytes of the frail elderly[J]. Immun Ageing, 2022, 19(1):5.
|
| [21] |
Dent E, Hoogendijk EO, Moldovan M. Frailty index from routine laboratory measurements correlates with leukocyte telomere length: Letters to the Editor[J]. Geriatr Gerontol Int, 2018, 18(4):654-655.
|
| [22] |
Teixeira-Gomes A, Laffon B, Valdiglesias V, et al. Exploring early detection of frailty syndrome in older adults: Evaluation of oxi-immune markers, clinical parameters and modifiable risk factors[J]. Antioxidants (Basel), 2021, 10(12):1975.
|
| [23] |
Valdiglesias V, Marcos-Pérez D, Lorenzi M, et al. Immunological alterations in frail older adults: A cross sectional study[J]. Exp Gerontol, 2018, 112:119-126.
|
| [24] |
Xu W, Liang Y, Lin Z. Association between neutrophil-lymphocyte ratio and frailty: The chinese longitudinal healthy longevity survey[J]. Front Med (Lausanne), 2021, 8:783077.
|
| [25] |
Wilson D, Drew W, Jasper A, et al. Frailty is associated with neutrophil dysfunction which is correctable with phosphoinositol-3-kinase inhibitors[J]. J Gerontol A Biol Sci Med Sci, 2020, 75(12):2320-2325.
|
| [26] |
Blacher E, Tsai C, Litichevskiy L, et al. Aging disrupts circadian gene regulation and function in macrophages[J]. Nat Immunol, 2022, 23(2):229-236.
|
| [27] |
Kadoguchi T, Shimada K, Miyazaki T, et al. Promotion of oxidative stress is associated with mitochondrial dysfunction and muscle atrophy in aging mice[J]. Geriatr Gerontol Int, 2020, 20(1):78-84.
|
| [28] |
Wu IC, Shiesh SC, Kuo PH, et al. High oxidative stress is correlated with frailty in elderly chinese[J]. J Am Geriatr Soc, 2009, 57(9):1666-1671.
|
| [29] |
Serviddio G, Romano AD, Greco A, et al. Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress[J]. Int J Immunopathol Pharmacol, 2009, 22(3):819-827.
|
| [30] |
Kameda M, Teruya T, Yanagida M, et al. Frailty markers comprise blood metabolites involved in antioxidation, cognition, and mobility[J]. Proc Natl Acad Sci U S A, 2020, 117(17):9483-9489.
|
| [31] |
éCT R, Sangali TD, Clausell NO, et al. C-reactive protein and frailty in heart failure[J]. Am J Cardiol, 2022, 166:65-71.
|
| [32] |
Sadjapong U, Yodkeeree S, Sungkarat S, et al. Multicomponent exercise program reduces frailty and inflammatory biomarkers and improves physical performance in community-dwelling older adults: A randomized controlled trial[J]. Int J Environ Res Public Health, 2020, 17(11):3760.
|
| [33] |
Yang Y, Hao Q, Flaherty JH, et al. Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 and C-reactive protein among older Chinese hospitalized patients[J]. Aging Clin Exp Res, 2018, 30(12):1459-1464.
|
| [34] |
Pilotto A, Dini S, Daragjati J, et al. Combined use of the multidimensional prognostic index (MPI) and procalcitonin serum levels in predicting 1-month mortality risk in older patients hospitalized with community-acquired pneumonia (CAP): A prospective study[J]. Aging Clin Exp Res, 2018, 30(2):193-197.
|
| [35] |
Lee WJ, Chen LK, Liang CK, et al. Soluble ICAM-1, independent of IL-6, is associated with prevalent frailty in community-dwelling elderly taiwanese people[J/OL]. PLoS One, 2016, 11(6):e0157877.
|
| [36] |
Kou L, Yang N, Dong B, et al. Interaction between SELP genetic polymorphisms with inflammatory cytokine interleukin-6 (IL-6) gene variants on cardiovascular disease in Chinese Han population[J]. Mamm Genome, 2017, 28(9-10):436-442.
|
| [37] |
Hernández B, Fuentes E, Palomo I, et al. Increased platelet function during frailty[J]. Exp Hematol, 2019, 77:12-25.e2.
|
| [38] |
Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man[J]. Biochem Soc Trans, 2017, 45(5):1105-1115.
|
| [39] |
Angulo J, El Assar M, álvarez-Bustos A, et al. Physical activity and exercise: Strategies to manage frailty[J]. Redox Biol, 2020, 35:101513.
|